close
Choose your channels

Good news: Cancer drugs become much cheaper in India

Monday, May 20, 2019 • Common Comments
Listen to article
--:-- / --:--
1x
This is a beta feature and we would love to hear your feedback?
Send us your feedback to audioarticles@vaarta.com

A welcome decision has been taken by the National Pharmaceutical Pricing Authority (NPPA) to reduce the prices of anti-cancer drugs.

The body recently released a memorandum ruling that 9 anti-cancer drugs have been brought under its price control framework. As a consequence, the retail prices of the drugs have come down by up to 87 percent. This is phenomenal.

"The trade margin of the 9 drugs has been capped at 30 percent," the order says.

The Centre has been taking steps to "curb profiteering" on vital drugs sold in India.

A report says that the decisions taken by the Government will benefit 22 lakh cancer patients in India.

Follow us on Google News and stay updated with the latest!   

Comments

Welcome to IndiaGlitz comments! Please keep conversations courteous and relevant to the topic. To ensure productive and respectful discussions, you may see comments from our Community Managers, marked with an "IndiaGlitz Staff" label. For more details, refer to our community guidelines.
settings
Login to post comment
Cancel
Comment